A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
Hoosier Cancer Research Network
Hoosier Cancer Research Network
National Cancer Institute (NCI)
AHS Cancer Control Alberta
Canadian Cancer Trials Group
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Pisa
Leaf Vertical Inc.
Vanderbilt-Ingram Cancer Center
UNICANCER
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Stanford University
Federation Francophone de Cancerologie Digestive
University of Utah
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
New Mexico Cancer Research Alliance
Assistance Publique - Hôpitaux de Paris